AGAlan John Guthrie

Alan John Guthrie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alan John Guthrie has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Review of Pseudomonas aeruginosa and Klebsiella pneumoniae as venereal pathogens in horses

    by Melanie Scholtz, Alan John Guthrie, Richard Newton, Martin Lance Schulman

    Three bacteria extensively acknowledged as venereal pathogens with the potential to induce endometritis include Taylorella equigenitalis , the causative agent of contagious equine metritis (CEM), specific strains of Pseudomonas aeruginosa , and certain capsule types of Klebsiella pneumoniae . The United Kingdom's Horserace Betting Levy Board recommends pre‐breeding screening for these bacteria in their International Codes of Practice and >20 000 samples are tested per annum in the United Kingdom alone. While the pathogenesis and regulatory importance of CEM are well established, an evaluation of the literature pertaining to venereal transmission of P. aeruginosa and K. pneumoniae was lacking. The aim of this review was to evaluate published literature and determine the significance of P. aeruginosa and K. pneumoniae as venereal pathogens in horses. Literature definitively demonstrating venereal transmission was not available. Instead, application of molecular typing methods suggested that common environmental sources of contamination, such as water, or fomites be considered as modes of transmission. The presence of organisms with pathogenic potential on a horse's external genitalia did not predict venereal transmission with resultant endometritis and reduced fertility. These findings may prompt further investigation using molecular technologies to confirm or exclude venereal spread and investigation of alternative mechanisms of transmission are indicated.


  • Open Access

    Bluetongue Virus Infection in Farm Dogs Exposed to an Infected Sheep Flock in South Africa

    by Josef Hanekom, Karen Ebersohn, Lisa Penzhorn, Melvyn Quan, Andrew Leisewitz, Alan Guthrie, Geoffrey T. Fosgate

    In 2021, a pregnant Rottweiler dog living on a sheep farm was diagnosed with clinical bluetongue (BT) infection. This study reports on the investigation of this farm where bluetongue virus (BTV) infection was diagnosed in this atypical host species. Samples were collected during farm visits 14, 28, 60, and 89 days after the onset of clinical signs in the pregnant Rottweiler. Blood was collected from all farm dogs (n = 6) and tested for BTV genome using a reverse‐transcriptase quantitative PCR (RT‐qPCR) assay and BTV antibodies with the competitive ELISA (cELISA) and dogs positive by RT‐qPCR were further tested using virus neutralization (VN) serological testing. Blood was also collected from 16 sick sheep and tested using RT‐qPCR. Midges were trapped on the study farm using an Onderstepoort UV light trap placed above a sheep pen for 36 hr at the first farm (14 days) visit. Parous/gravid midges were tested by BTV RT‐qPCR in batches of up to 200 midges per species. Blood‐fed midges (n = 308) were tested using a PCR species probe (KAPA Multiplex Master Mix) to identify the host species on which the midge had fed. Three dogs (n = 3/6) had detectable BTV RNA with RT‐qPCR and high VN antibody titers to BTV. All RT‐qPCR‐positive dogs and one additional dog tested cELISA seropositive (n = 4/6). Bluetongue virus RNA was detected in 5/16 sheep tested. The most abundant midge species was Culicoides imicola (99.3%) and BTV was only detected in this species (n = 3/4 batches of 200 parous midges). Dog blood was not detected in any blood‐fed midges tested. The occurrence of natural BT viraemia in exposed dogs creates a potential risk of BTV entry into BT‐free countries through dog importation. It remains unclear whether BT viremia in dogs is capable of onward transmission.


  • Predictors of foaling outcomes in barren and maiden Thoroughbred mares in South Africa

    by M Scholtz, A J Guthrie, G T Fosgate, M L Schulman

    Population demographics and reproductive performance of Thoroughbred populations have been described, but the most recent assessment of the South African Thoroughbred population was reported two decades ago. Objectives of this study were to report demographic data for selected Thoroughbred breeding populations and to analyse selected mare-level variables in association with foaling outcomes, as predictors of reproductive performance. The National Horseracing Authority of Southern Africa's stud health scheme requires annual screening of Thoroughbred stallions, maiden and barren mares for venereal pathogens prior to breeding. In 2018 and 2019, 1 065 and 1 207 horses were sampled, respectively. Demographic data were sourced from laboratory sample submission forms that accompanied samples and supplemented by data gathered from the annual Thoroughbred foal identification programme. Univariate analysis of candidate predictors of successful foaling outcomes was performed followed by assessment in a multivariable model.Median ages of mares and stallions tested in 2018 and 2019 were nine and 11 years, respectively. Nearly twice the number of barren compared to maiden mares were tested in each year, and failure to conceive was the most common reported reason for classification as barren. Of mares tested in 2018 and 2019, 68.1% (95% CI 65.1, 70.9) and 63.3% (95% CI 60.4, 66.1), respectively, subsequently produced foals that were presented for identification. Mare age, rather than reproductive status, was a significant predictor of having a foal presented for identification. In conclusion, novel demographic data were described for South African Thoroughbred populations. Seasonal foaling rate as the selected measure of reproductive performance for sampled mares ranged from 63.3% to 68.1% and declined with increasing mare age.

  • Open Access

    Clinical Course of Infection and Cross-Species Detection of Equine Parvovirus-Hepatitis

    by Birthe Reinecke, Mara Klöhn, Yannick Brüggemann, Volker Kinast, Daniel Todt, Alexander Stang, Marcha Badenhorst, Katja Koeppel, Alan Guthrie, Ursula Groner, et al.

    Since its first discovery by Arnold Theiler in 1918, serum hepatitis also known as Theiler’s disease has been reported worldwide, causing idiopathic acute hepatitis and liver failure in horses. Recent studies have suggested a novel parvovirus, named equine parvovirus hepatitis (EqPV-H), to be associated with Theiler’s disease. Despite the severity and potential fatality of EqPV-H infection, little is known about the possibility of developing chronic infections and putative cross-species infection of equine sister species. In the present longitudinal study, we employed qPCR analysis, serology, and biochemical testing as well as pathology examination of liver biopsies and sequence analysis to investigate potential chronic EqPV-H infection in an isolated study cohort of in total 124 horses from Germany over five years (2013–2018). Importantly, our data suggest that EqPV-H viremia can become chronic in infected horses that do not show biochemical and pathological signs of liver disease. Phylogenetic analysis by maximum likelihood model also confirms high sequence similarity and nucleotide conservation of the multidomain nuclear phosphoprotein NS1 sequences from equine serum samples collected between 2013–2018. Moreover, by examining human, zebra, and donkey sera for the presence of EqPV-H DNA and VP1 capsid protein antibodies, we found evidence for cross-species infection in donkey, but not to human and zebra. In conclusion, this study provides proof for the occurrence of persistent EqPV-H infection in asymptomatic horses and cross-species EqPV-H detection in donkeys.


  • Open Access

    Complete Genome Sequences of Virus Strains Isolated from Bottle A of the South African Live Attenuated Bluetongue Virus Vaccine

    by Peter Coetzee, Alan J Guthrie, Karen Ebersohn, James N Maclachlan, Arshad Ismail, Antoinette Van Schalkwyk, Estelle H Venter

    This is a report of the complete genome sequences of plaque-selected isolates of five virus strains included in bottle A of the South African Onderstepoort Biological Products commercial live attenuated bluetongue virus vaccine.


  • First detection and frequent occurrence of Equine Hepacivirus in horses on the African continent

    by Marcha Badenhorst, Birthe Tegtmeyer, Daniel Todt, Alan Guthrie, Karsten Feige, Amely Campe, Eike Steinmann, Jessika M.V. Cavalleri


  • Open Access

    The sero-prevalence and sero-incidence of African horse sickness and equine encephalosis in selected horse and donkey populations in Zimbabwe

    by Stuart J.G. Gordon, Charlotte Bolwell, Chris W. Rogers, Godfrey Musuka, Patrick Kelly, Alan Guthrie, Philip S. Mellor, Christopher Hamblin

    Sentinel herds and samples submitted by private equine practitioners were used to determine the sero-prevalence and sero-incidence of African horse sickness virus (AHSV) and equine encephalosis virus (EEV) in horse and donkey populations in the Highveld region of Zimbabwe. The sero-prevalence and sero-incidence of antibodies against these viruses were determined using the competitive enzyme-linked immunosorbent assay (ELISA) for the detection of serum antibodies. In donkeys, the median sero-prevalence of AHSV antibodies, across the three rainy seasons under study, was 75% (inter quartile range [IQR] 67–83), with a seasonal median sero-incidence of 45% (IQR 40–63). In horses, the median sero-prevalence of EEV antibodies was 63% (IQR 21–73), with a median seasonal sero-incidence of 10.5% (IQR 10–14), while in donkeys the median sero-prevalence of EEV antibodies was 80% (IQR 67–90), with a median seasonal sero-incidence of 50% (IQR 40–60). This study highlighted the significant levels of exposure of donkeys to AHSV and horses and donkeys to EEV in Zimbabwe despite equine encephalosis remaining unreported by Zimbabwean veterinarians to date. Most seroconversions in sentinel herd animals to AHSV and EEV occurred towards the end of the rainy season in March, April and May corresponding to the time of the year when the Culicoides vectors are in high abundance. In order to determine the clinical significance of these infections, blood and spleen samples, submitted by private equine veterinary practitioners over a 5-year period, from horses showing characteristic clinical signs of African horse sickness were tested for the presence of viral antigen using the antigen capture ELISA. The median sero-prevalence of AHSV antigen in horses recorded from these samples was 38% (IQR 33–88). The predominant AHSV antigen from these samples was serotype 7 (33%) followed by serotype 2 (26%) and serotypes 4 and 8 (16% each). African horse sickness virus serotypes 3 and 9, identified in this study, had not been previously reported in Zimbabwe.


  • Open Access

    A serosurvey of bluetongue and epizootic haemorrhagic disease in a convenience sample of sheep and cattle herds in Zimbabwe

    by Stuart J.G. Gordon, Charlotte Bolwell, Chris W. Rogers, Godfrey Musuka, Patrick Kelly, Alan Guthrie, Philip S. Mellor, Chris Hamblin

    A convenience sample of sheep and cattle herds around the cities of Harare, Kwekwe and Bulawayo, located in the Highveld region of Zimbabwe, was used to estimate the seroprevalence and sero-incidence of bluetongue virus (BTV) and epizootic haemorrhagic disease virus (EHDV) antibodies. A competitive enzyme-linked immunosorbent assay was used to identify serum antibodies against BTV and EHDV across three rainy seasons. The median sero-prevalence of BTV and EHDV antibodies in cattle was 62% (interquartile range [IQR]: 30–89) and 56% (IQR: 5–77), respectively. In sheep, the median sero-prevalence of BTV and EHDV was 41% (IQR: 19–63) and 0% (IQR: 0–21), respectively. Median sero-incidences of BTV and EHDV antibodies in cattle of 43% (IQR: 22–67) and 27% (IQR: 9–57) respectively were recorded. The median sero-incidence of BTV in sheep was 14% (IQR: 6–23). Based on these preliminary findings, animal health workers in Zimbabwe should continue to monitor the exposure rates of cattle and sheep to BTV and consider the possibility of strains emerging with increased pathogenicity. There are no previous published reports of antibodies against EHDV in Zimbabwe so the possibility of epizootic haemorrhagic disease existing in domestic livestock should now be considered by Zimbabwean animal health officials. Seroconversions to BTV and EHDV occurred predominantly at the end of each rainy season (March and April), which generally corresponds to high numbers of the Culicoides vectors. BTV isolations were made from three individual cows in two of the sentinel herds and all three were identified as serotype 3. This is the first time BTV serotype 3 has been recorded in Zimbabwe, although its presence in neighbouring South Africa is well documented.


  • Open Access

    African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004–2014

    by Camilla T. Weyer, John D. Grewar, Phillippa Burger, Esthea Rossouw, Carina Lourens, Christopher Joone, Misha le Grange, Peter Coetzee, Estelle Venter, Darren P. Martin, et al.

    African horse sickness (AHS) is a hemorrhagic viral fever of horses. It is the only equine disease for which the World Organization for Animal Health has introduced specific guidelines for member countries seeking official recognition of disease-free status. Since 1997, South Africa has maintained an AHS controlled area; however, sporadic outbreaks of AHS have occurred in this area. We compared the whole genome sequences of 39 AHS viruses (AHSVs) from field AHS cases to determine the source of 3 such outbreaks. Our analysis confirmed that individual outbreaks were caused by virulent revertants of AHSV type 1 live, attenuated vaccine (LAV) and reassortants with genome segments derived from AHSV types 1, 3, and 4 from a LAV used in South Africa. These findings show that despite effective protection of vaccinated horses, polyvalent LAV may, paradoxically, place susceptible horses at risk for AHS.